Shanghai Chemspec Corporation (SHA:688602)
China · Delayed Price · Currency is CNY 7.50
+0.55 (7.91%)
At close: Jun 10, 2026
Shanghai Chemspec Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 646.54 | 739.84 | 653.13 | 951.48 | 1,209 | 967.07 |
Other Revenue | 29.74 | 29.74 | 21.68 | 28.11 | 28.83 | 37.56 |
| 676.29 | 769.58 | 674.81 | 979.59 | 1,238 | 1,005 | |
Revenue Growth (YoY) | -9.76% | 14.04% | -31.11% | -20.89% | 23.25% | 59.67% |
Cost of Revenue | 665.24 | 712.78 | 629.76 | 723.74 | 885.37 | 667.06 |
Gross Profit | 11.04 | 56.8 | 45.06 | 255.85 | 352.83 | 337.57 |
Selling, General & Admin | 88.92 | 84.87 | 98.24 | 95.33 | 98.17 | 83.48 |
Research & Development | 76.22 | 75.71 | 85.39 | 86.86 | 86.78 | 74.96 |
Other Operating Expenses | 8.09 | 5.76 | 2.56 | 5.82 | 8.03 | 8.7 |
Operating Expenses | 176.06 | 167.65 | 187.11 | 186.44 | 191.31 | 167.61 |
Operating Income | -165.01 | -110.85 | -142.05 | 69.41 | 161.52 | 169.97 |
Interest Expense | -4.96 | -5.49 | -7.4 | -9.08 | -6.93 | -9.05 |
Interest & Investment Income | 15.35 | 18.45 | 63.12 | 18.01 | 1.37 | 20.92 |
Earnings From Equity Investments | 3.33 | - | - | - | 29.72 | - |
Currency Exchange Gain (Loss) | 1.49 | 1.49 | 5.03 | 4.75 | -0.14 | -1.91 |
Other Non Operating Income (Expenses) | -3.13 | 0.16 | -2.82 | -0.65 | -0.83 | -0.54 |
EBT Excluding Unusual Items | -152.93 | -96.25 | -84.12 | 82.44 | 184.7 | 179.38 |
Gain (Loss) on Sale of Investments | 11.96 | 9.72 | 8.78 | 4.73 | 4.44 | -41.15 |
Gain (Loss) on Sale of Assets | -1.46 | -1.5 | -0.71 | 25.62 | -2.48 | -0.13 |
Asset Writedown | -4.36 | -7.14 | - | - | - | -2.72 |
Other Unusual Items | 12.75 | 12.64 | 4.24 | 13.02 | 13.81 | 10.16 |
Pretax Income | -134.05 | -82.53 | -71.81 | 125.81 | 200.48 | 147.04 |
Income Tax Expense | -25.69 | -16.21 | -21.15 | 10.68 | 17.79 | 8.75 |
Earnings From Continuing Operations | -108.36 | -66.31 | -50.66 | 115.13 | 182.68 | 138.29 |
Minority Interest in Earnings | 0.94 | 2.11 | 1.12 | -2.43 | -2.12 | -4.22 |
Net Income | -107.42 | -64.2 | -49.53 | 112.7 | 180.56 | 134.07 |
Net Income to Common | -107.42 | -64.2 | -49.53 | 112.7 | 180.56 | 134.07 |
Net Income Growth | - | - | - | -37.59% | 34.68% | 48.51% |
Shares Outstanding (Basic) | 565 | 535 | 495 | 451 | 420 | 388 |
Shares Outstanding (Diluted) | 565 | 535 | 495 | 451 | 420 | 388 |
Shares Change (YoY) | 12.25% | 8.01% | 9.88% | 7.35% | 8.29% | 7.71% |
EPS (Basic) | -0.19 | -0.12 | -0.10 | 0.25 | 0.43 | 0.35 |
EPS (Diluted) | -0.19 | -0.12 | -0.10 | 0.25 | 0.43 | 0.35 |
EPS Growth | - | - | - | -41.86% | 24.37% | 38.30% |
Free Cash Flow | -120.06 | 12.26 | -100.83 | 81.41 | 13.19 | -76.08 |
Free Cash Flow Per Share | -0.21 | 0.02 | -0.20 | 0.18 | 0.03 | -0.20 |
Dividend Per Share | - | - | - | 0.066 | - | - |
Gross Margin | 1.63% | 7.38% | 6.68% | 26.12% | 28.49% | 33.60% |
Operating Margin | -24.40% | -14.40% | -21.05% | 7.09% | 13.04% | 16.92% |
Profit Margin | -15.88% | -8.34% | -7.34% | 11.51% | 14.58% | 13.35% |
Free Cash Flow Margin | -17.75% | 1.59% | -14.94% | 8.31% | 1.06% | -7.57% |
EBITDA | -4.18 | 48.5 | 11.36 | 195.99 | 283.08 | 265.28 |
EBITDA Margin | -0.62% | 6.30% | 1.68% | 20.01% | 22.86% | 26.41% |
D&A For EBITDA | 160.84 | 159.35 | 153.41 | 126.58 | 121.57 | 95.31 |
EBIT | -165.01 | -110.85 | -142.05 | 69.41 | 161.52 | 169.97 |
EBIT Margin | -24.40% | -14.40% | -21.05% | 7.09% | 13.04% | 16.92% |
Effective Tax Rate | - | - | - | 8.49% | 8.88% | 5.95% |
Revenue as Reported | 676.29 | 769.58 | 674.81 | 979.59 | 1,238 | - |
Advertising Expenses | - | 1.12 | 0.65 | 0.67 | 0.11 | 0.39 |